Autonomous Healthcare Creates New FDA Device Category with Syncron-Eâ„¢
SANTA CLARA, Calif., July 14, 2026 Autonomous Healthcare has achieved a landmark regulatory milestone after the U.S. Food and...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Medical Devices, Diagnostics, Radiation-Emitting Products
SANTA CLARA, Calif., July 14, 2026 Autonomous Healthcare has achieved a landmark regulatory milestone after the U.S. Food and...
IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...
BASEL, Switzerland, July 14, 2026 Roche has introduced the cobas® Hepatitis D Virus (HDV) test, the first fully automated,...
MINNEAPOLIS, Minn., July 13, 2026 HistoSonics has achieved a major international regulatory milestone after receiving CE Mark approval for...
SAN FRANCISCO, Calif., July 13, 2026 Universal Brain has achieved a significant regulatory milestone after receiving U.S. Food and...
CARLSBAD, California, July 13, 2026 ALZpath, Inc. has announced a major scientific milestone at the Alzheimer’s Association International Conference...
LONE TREE, Colorado, July 13, 2026 Cochlear Limited, a global leader in implantable hearing solutions, has announced U.S. FDA...
VANCOUVER, British Columbia, July 6, 2026 Cannabix Technologies announced the successful detection of cocaine and its primary metabolite, benzoylecgonine,...
EINDHOVEN, The Netherlands, July 7, 2026 Xeltis has announced the first commercial implantation of its aXessâ„¢ vascular access device,...
TORONTO, July 8, 2026 Conavi Medical Corp. announced the publication of a clinical case report in the Journal of...
